Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Chris Shibutani's Stock Ratings
Goldman Sachs Analyst
Chris Shibutani is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/08/2025
Overall Average Return
2.41%
Smart Score
Overall Average Return Percentile
45th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/01/2025 | PCVX | Buy Now | Vaxcyte | $33.45 | 198.95% | Chris Shibutani57% | $138 → $100 | Maintains | Buy | Get Alert |
| 03/21/2025 | ERAS | Buy Now | Erasca | $1.41 | 112.77% | Chris Shibutani57% | $3.5 → $3 | Maintains | Buy | Get Alert |
| 03/14/2025 | MCRB | Buy Now | Seres Therapeutics | $7.48 | -89.97% | Chris Shibutani57% | $1 → $0.75 | Maintains | Sell | Get Alert |
| 02/14/2025 | ALKS | Buy Now | Alkermes | $30.78 | 3.96% | Chris Shibutani57% | $30 → $32 | Maintains | Buy | Get Alert |
| 12/20/2024 | PCVX | Buy Now | Vaxcyte | $33.45 | 303.59% | Chris Shibutani57% | → $135 | Initiates | → Buy | Get Alert |
| 11/08/2024 | BNTX | Buy Now | BioNTech | $95.51 | 43.44% | Chris Shibutani57% | $90 → $137 | Upgrade | Neutral → Buy | Get Alert |
| 11/07/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $11.06 | 198.24% | Chris Shibutani57% | $30 → $33 | Maintains | Buy | Get Alert |
| 11/01/2024 | UTHR | Buy Now | United Therapeutics | $310.10 | -2.61% | Chris Shibutani57% | $243 → $302 | Maintains | Neutral | Get Alert |
| 10/25/2024 | ALKS | Buy Now | Alkermes | $30.78 | -2.53% | Chris Shibutani57% | $32 → $30 | Maintains | Buy | Get Alert |
| 10/25/2024 | ERAS | Buy Now | Erasca | $1.41 | 148.23% | Chris Shibutani57% | $3 → $3.5 | Maintains | Buy | Get Alert |
| 08/14/2024 | ERAS | Buy Now | Erasca | $1.41 | 112.77% | Chris Shibutani57% | $4 → $3 | Maintains | Buy | Get Alert |
| 08/14/2024 | RPRX | Buy Now | Royalty Pharma | $33.07 | 54.22% | Chris Shibutani57% | $50 → $51 | Maintains | Buy | Get Alert |
| 07/19/2024 | JNJ | Buy Now | Johnson & Johnson | $156.31 | -0.83% | Chris Shibutani57% | $160 → $155 | Maintains | Neutral | Get Alert |
| 07/12/2024 | AMLX | Buy Now | Amylyx Pharma | $4.88 | -18.03% | Chris Shibutani57% | $3 → $4 | Maintains | Neutral | Get Alert |
| 05/28/2024 | ERAS | Buy Now | Erasca | $1.41 | 183.69% | Chris Shibutani57% | $7 → $4 | Maintains | Buy | Get Alert |
| 05/13/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | Chris Shibutani57% | $9 → $8 | Maintains | Neutral | Get Alert |
| 05/06/2024 | OGN | Buy Now | Organon | $9.12 | 119.42% | Chris Shibutani57% | $18 → $20 | Maintains | Neutral | Get Alert |
| 05/03/2024 | UTHR | Buy Now | United Therapeutics | $310.10 | -22.61% | Chris Shibutani57% | $218 → $240 | Maintains | Neutral | Get Alert |
| 05/03/2024 | OGN | Buy Now | Organon | $9.12 | 119.42% | Chris Shibutani57% | $18 → $20 | Maintains | Neutral | Get Alert |
| 04/11/2024 | LLY | Buy Now | Eli Lilly and Co | $751.27 | -3.76% | Chris Shibutani57% | $650 → $723 | Maintains | Neutral | Get Alert |
| 04/02/2024 | ERAS | Buy Now | Erasca | $1.41 | 396.45% | Chris Shibutani57% | $6 → $7 | Maintains | Buy | Get Alert |
| 03/11/2024 | AMLX | Buy Now | Amylyx Pharma | $4.88 | -18.03% | Chris Shibutani57% | $40 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 03/01/2024 | SDGR | Buy Now | Schrodinger | $24.27 | 7.14% | Chris Shibutani57% | $29 → $26 | Maintains | Neutral | Get Alert |
| 03/01/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | Chris Shibutani57% | $8 → $9 | Maintains | Neutral | Get Alert |
| 02/28/2024 | BNTX | Buy Now | BioNTech | $95.51 | 4.7% | Chris Shibutani57% | $113 → $100 | Maintains | Neutral | Get Alert |
| 02/20/2024 | RPRX | Buy Now | Royalty Pharma | $33.07 | 51.19% | Chris Shibutani57% | $56 → $50 | Maintains | Buy | Get Alert |
| 02/20/2024 | OGN | Buy Now | Organon | $9.12 | 97.48% | Chris Shibutani57% | $16 → $18 | Maintains | Neutral | Get Alert |
| 02/12/2024 | UTHR | Buy Now | United Therapeutics | $310.10 | -30.67% | Chris Shibutani57% | $213 → $215 | Upgrade | Sell → Neutral | Get Alert |
| 01/25/2024 | NBIX | Buy Now | Neurocrine Biosciences | $120.09 | 27.4% | Chris Shibutani57% | $134 → $153 | Maintains | Buy | Get Alert |
| 01/09/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | Chris Shibutani57% | $30 → $8 | Downgrade | Buy → Neutral | Get Alert |
| 12/11/2023 | ABBV | Buy Now | AbbVie | $185.67 | -6.82% | Chris Shibutani57% | → $173 | Upgrade | Neutral → Buy | Get Alert |
| 11/10/2023 | AMLX | Buy Now | Amylyx Pharma | $4.88 | 719.67% | Chris Shibutani57% | $46 → $40 | Maintains | Buy | Get Alert |
| 11/09/2023 | NKTR | Buy Now | Nektar Therapeutics | $0.61 | — | Chris Shibutani57% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/03/2023 | MCRB | Buy Now | Seres Therapeutics | $7.48 | -83.29% | Chris Shibutani57% | $4 → $1.25 | Maintains | Sell | Get Alert |
| 11/03/2023 | OGN | Buy Now | Organon | $9.12 | 75.53% | Chris Shibutani57% | $33 → $16 | Downgrade | Buy → Neutral | Get Alert |
| 10/30/2023 | BMY | Buy Now | Bristol-Myers Squibb | $47.16 | 46.33% | Chris Shibutani57% | $81 → $69 | Maintains | Buy | Get Alert |
| 10/11/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $11.06 | 171.13% | Chris Shibutani57% | → $30 | Initiates | → Buy | Get Alert |
| 09/21/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | Chris Shibutani57% | $38 → $33 | Maintains | Buy | Get Alert |
| 08/10/2023 | LLY | Buy Now | Eli Lilly | $751.27 | -37.44% | Chris Shibutani57% | $385 → $470 | Maintains | Neutral | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $751.27 | -37.44% | Chris Shibutani57% | $385 → $470 | Maintains | Neutral | Get Alert |
| 07/24/2023 | AMLX | Buy Now | Amylyx Pharma | $4.88 | 904.1% | Chris Shibutani57% | $45 → $49 | Upgrade | Neutral → Buy | Get Alert |
| 05/16/2023 | ERAS | Buy Now | Erasca | $1.41 | 538.3% | Chris Shibutani57% | $10 → $9 | Maintains | Buy | Get Alert |
| 05/10/2023 | EQRX | Buy Now | EQRx | — | — | Chris Shibutani57% | $5 → $3 | Maintains | Neutral | Get Alert |
| 03/28/2023 | BNTX | Buy Now | BioNTech | $95.51 | 46.58% | Chris Shibutani57% | $156 → $140 | Maintains | Neutral | Get Alert |
| 03/14/2023 | AMLX | Buy Now | Amylyx Pharma | $4.88 | 863.11% | Chris Shibutani57% | $41 → $47 | Maintains | Neutral | Get Alert |
| 03/03/2023 | INVA | Buy Now | Innoviva | $18.34 | -29.1% | Chris Shibutani57% | $15 → $13 | Maintains | Neutral | Get Alert |
| 03/01/2023 | RVMD | Buy Now | Revolution Medicines | $41.77 | -44.94% | Chris Shibutani57% | $20 → $23 | Maintains | Neutral | Get Alert |
| 02/27/2023 | NKTR | Buy Now | Nektar Therapeutics | $0.61 | 227.82% | Chris Shibutani57% | $3 → $2 | Maintains | Sell | Get Alert |
| 02/24/2023 | ERAS | Buy Now | Erasca | $1.41 | 609.22% | Chris Shibutani57% | → $10 | Initiates | → Buy | Get Alert |
| 01/31/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | Chris Shibutani57% | $117 → $144 | Maintains | Buy | Get Alert |
| 01/31/2023 | BNTX | Buy Now | BioNTech | $95.51 | 63.33% | Chris Shibutani57% | $177 → $156 | Maintains | Neutral | Get Alert |
| 12/19/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.21 | 4032.23% | Chris Shibutani57% | → $50 | Initiates | → Buy | Get Alert |
| 12/16/2022 | KYMR | Buy Now | Kymera Therapeutics | $30.91 | 68.2% | Chris Shibutani57% | $40 → $52 | Maintains | Buy | Get Alert |
| 12/13/2022 | PFE | Buy Now | Pfizer | $23.02 | 160.67% | Chris Shibutani57% | $47 → $60 | Upgrade | Neutral → Buy | Get Alert |
| 12/05/2022 | UTHR | Buy Now | United Therapeutics | $310.10 | -25.83% | Chris Shibutani57% | → $230 | Initiates | → Sell | Get Alert |
| 11/11/2022 | EQRX | Buy Now | EQRx | — | — | Chris Shibutani57% | $8 → $5 | Downgrade | Buy → Neutral | Get Alert |
| 11/08/2022 | TRDA | Buy Now | Entrada Therapeutics | $8.16 | 120.59% | Chris Shibutani57% | $13 → $18 | Maintains | Neutral | Get Alert |
| 11/08/2022 | LLY | Buy Now | Eli Lilly | $751.27 | -58.34% | Chris Shibutani57% | $281 → $313 | Maintains | Neutral | Get Alert |
| 11/08/2022 | BNTX | Buy Now | BioNTech | $95.51 | 85.32% | Chris Shibutani57% | $200 → $177 | Maintains | Neutral | Get Alert |
| 09/22/2022 | RVNC | Buy Now | Revance Therapeutics | — | — | Chris Shibutani57% | → $33 | Initiates | → Buy | Get Alert |
| 09/09/2022 | AMLX | Buy Now | Amylyx Pharma | $4.88 | 719.67% | Chris Shibutani57% | $22 → $40 | Maintains | Neutral | Get Alert |
| 08/16/2022 | TRDA | Buy Now | Entrada Therapeutics | $8.16 | 59.31% | Chris Shibutani57% | $10 → $13 | Maintains | Neutral | Get Alert |
| 08/03/2022 | KYMR | Buy Now | Kymera Therapeutics | $30.91 | 29.39% | Chris Shibutani57% | → $40 | Initiates | → Buy | Get Alert |
| 07/20/2022 | INVA | Buy Now | Innoviva | $18.34 | -12.74% | Chris Shibutani57% | → $16 | Initiates | → Neutral | Get Alert |
| 07/20/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Chris Shibutani57% | → $51 | Initiates | → Buy | Get Alert |
| 06/13/2022 | EQRX | Buy Now | EQRx | — | — | Chris Shibutani57% | → $8 | Initiates | → Buy | Get Alert |
| 05/24/2022 | EXAI | Buy Now | Exscientia | — | — | Chris Shibutani57% | $23 → $20 | Maintains | Buy | Get Alert |
| 05/24/2022 | TRDA | Buy Now | Entrada Therapeutics | $8.16 | 22.55% | Chris Shibutani57% | $22 → $10 | Maintains | Neutral | Get Alert |
| 05/24/2022 | BNTX | Buy Now | BioNTech | $95.51 | 115.68% | Chris Shibutani57% | $255 → $206 | Maintains | Neutral | Get Alert |
| 04/27/2022 | OGN | Buy Now | Organon | $9.12 | 338.84% | Chris Shibutani57% | → $40 | Initiates | → Buy | Get Alert |
| 04/27/2022 | RPRX | Buy Now | Royalty Pharma | $33.07 | 69.34% | Chris Shibutani57% | → $56 | Initiates | → Buy | Get Alert |
| 04/20/2022 | ALKS | Buy Now | Alkermes | $30.78 | 13.71% | Chris Shibutani57% | → $35 | Initiates | → Buy | Get Alert |
| 04/18/2022 | NKTR | Buy Now | Nektar Therapeutics | $0.61 | 391.72% | Chris Shibutani57% | → $3 | Downgrade | Neutral → Sell | Get Alert |
| 04/12/2022 | JNJ | Buy Now | Johnson & Johnson | $156.31 | 15.8% | Chris Shibutani57% | $163 → $181 | Maintains | Neutral | Get Alert |
| 04/12/2022 | LLY | Buy Now | Eli Lilly | $751.27 | -64.86% | Chris Shibutani57% | $234 → $264 | Maintains | Neutral | Get Alert |
| 04/12/2022 | ABBV | Buy Now | AbbVie | $185.67 | -24.6% | Chris Shibutani57% | $122 → $140 | Maintains | Neutral | Get Alert |
| 04/01/2022 | AMLX | Buy Now | Amylyx Pharma | $4.88 | 104.92% | Chris Shibutani57% | $36 → $10 | Downgrade | Buy → Neutral | Get Alert |
| 02/25/2022 | NBIX | Buy Now | Neurocrine Biosciences | $120.09 | -4.24% | Chris Shibutani57% | → $115 | Upgrade | Neutral → Buy | Get Alert |
| 02/03/2022 | ABBV | Buy Now | AbbVie | $185.67 | -34.29% | Chris Shibutani57% | $117 → $122 | Maintains | Neutral | Get Alert |
| 02/01/2022 | AMLX | Buy Now | Amylyx Pharma | $4.88 | 637.7% | Chris Shibutani57% | → $36 | Initiates | → Buy | Get Alert |
| 12/17/2021 | ABBV | Buy Now | AbbVie | $185.67 | -39.14% | Chris Shibutani57% | → $113 | Initiates | → Neutral | Get Alert |
| 12/17/2021 | PFE | Buy Now | Pfizer | $23.02 | 121.57% | Chris Shibutani57% | → $51 | Initiates | → Neutral | Get Alert |
| 12/17/2021 | JNJ | Buy Now | Johnson & Johnson | $156.31 | 3% | Chris Shibutani57% | → $161 | Initiates | → Neutral | Get Alert |
| 12/17/2021 | LLY | Buy Now | Eli Lilly | $751.27 | -68.59% | Chris Shibutani57% | → $236 | Initiates | → Neutral | Get Alert |
| 12/17/2021 | BMY | Buy Now | Bristol-Myers Squibb | $47.16 | 52.69% | Chris Shibutani57% | → $72 | Initiates | → Buy | Get Alert |
| 11/23/2021 | TRDA | Buy Now | Entrada Therapeutics | $8.16 | 255.39% | Chris Shibutani57% | → $29 | Initiates | → Neutral | Get Alert |
| 10/26/2021 | EXAI | Buy Now | Exscientia | — | — | Chris Shibutani57% | → $30 | Initiates | → Buy | Get Alert |
| 09/07/2021 | TNGX | Buy Now | Tango Therapeutics | $1.21 | 1304.96% | Chris Shibutani57% | → $17 | Initiates | → Buy | Get Alert |
| 08/12/2021 | RVMD | Buy Now | Revolution Medicines | $41.77 | -35.36% | Chris Shibutani57% | $49 → $27 | Downgrade | Buy → Neutral | Get Alert |
| 07/23/2021 | MCRB | Buy Now | Seres Therapeutics | $7.48 | -6.42% | Chris Shibutani57% | $24 → $7 | Downgrade | Neutral → Sell | Get Alert |
| 05/18/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Chris Shibutani57% | → $90 | Initiates | → Buy | Get Alert |
| 05/18/2021 | BNTX | Buy Now | BioNTech | $95.51 | 81.13% | Chris Shibutani57% | → $173 | Initiates | → Neutral | Get Alert |
| 05/18/2021 | RVMD | Buy Now | Revolution Medicines | $41.77 | 17.31% | Chris Shibutani57% | → $49 | Initiates | → Buy | Get Alert |
| 07/14/2020 | RPTX | Buy Now | Repare Therapeutics | $1.37 | — | Chris Shibutani57% | — | Initiates | → Outperform | Get Alert |
| 02/10/2020 | ARDX | Buy Now | Ardelyx | $3.74 | — | Chris Shibutani57% | — | Initiates | → Outperform | Get Alert |
| 01/10/2020 | ADRO | Buy Now | Aduro Biotech | — | — | Chris Shibutani57% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/15/2019 | ALKS | Buy Now | Alkermes | $30.78 | -12.28% | Chris Shibutani57% | → $27 | Upgrade | Sell → Neutral | Get Alert |
| 05/28/2019 | BMY | Buy Now | Bristol-Myers Squibb | $47.16 | 14.52% | Chris Shibutani57% | → $54 | Initiates | → Buy | Get Alert |
| 12/19/2018 | ALKS | Buy Now | Alkermes | $30.78 | -15.53% | Chris Shibutani57% | $49 → $26 | Downgrade | Neutral → Sell | Get Alert |
| 01/24/2018 | PBYI | Buy Now | Puma Biotechnology | $3.08 | — | Chris Shibutani57% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/21/2017 | MRTX | Buy Now | Mirati Therapeutics | — | — | Chris Shibutani57% | — | Initiates | → Outperform | Get Alert |
| 11/07/2017 | NKTR | Buy Now | Nektar Therapeutics | $0.61 | — | Chris Shibutani57% | — | Initiates | → Outperform | Get Alert |
| 07/18/2017 | ADRO | Buy Now | Aduro Biotech | — | — | Chris Shibutani57% | — | Initiates | → Outperform | Get Alert |
| 05/25/2017 | PBYI | Buy Now | Puma Biotechnology | $3.08 | — | Chris Shibutani57% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 05/02/2017 | RDUS | Buy Now | Radius Health | $29.37 | — | Chris Shibutani57% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/24/2017 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Chris Shibutani57% | — | Initiates | → Outperform | Get Alert |
| 03/24/2017 | SNDX | Buy Now | Syndax Pharmaceuticals | $11.06 | — | Chris Shibutani57% | — | Initiates | → Outperform | Get Alert |
| 05/06/2016 | RDUS | Buy Now | Radius Health | $29.37 | — | Chris Shibutani57% | — | Assumes | → Outperform | Get Alert |
| 07/21/2015 | MCRB | Buy Now | Seres Therapeutics | $7.48 | 381.28% | Chris Shibutani57% | → $36 | Initiates | → Neutral | Get Alert |
| 05/05/2015 | PBYI | Buy Now | Puma Biotechnology | $3.08 | — | Chris Shibutani57% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/16/2014 | RDUS | Buy Now | Radius Health | $29.37 | — | Chris Shibutani57% | — | Initiates | → Outperform | Get Alert |
| 01/05/2014 | ALKS | Buy Now | Alkermes | $30.78 | 20.21% | Chris Shibutani57% | $25 → $37 | Maintains | Neutral | Get Alert |
| 12/19/2012 | BMY | Buy Now | Bristol-Myers Squibb | $47.16 | -17.29% | Chris Shibutani57% | $40 → $39 | Maintains | Buy | Get Alert |
| 11/13/2012 | PBYI | Buy Now | Puma Biotech | $3.08 | — | Chris Shibutani57% | — | Initiates | → Outperform | Get Alert |
| 09/11/2012 | BMY | Buy Now | Bristol-Myers Squibb | $47.16 | -15.17% | Chris Shibutani57% | $38 → $40 | Upgrade | Buy → Buy | Get Alert |
| 05/18/2012 | ALKS | Buy Now | Alkermes | $30.78 | -44.77% | Chris Shibutani57% | $18 → $17 | Maintains | Neutral | Get Alert |
